logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Borrows, Jason Edward
    Born in August 1971
    Individual (34 offsprings)
    Officer
    2020-05-12 ~ now
    OF - Director → CIF 0
    Mr Jason Edward Borrows
    Born in August 1971
    Individual (34 offsprings)
    Person with significant control
    2020-05-12 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

KADEN BIOTECH LIMITED

Period: 2020-05-12 ~ now
Company number: 12598519
Registered name
KADEN BIOTECH LIMITED - now
Standard Industrial Classification
64205 - Activities Of Financial Services Holding Companies
Brief company account
Intangible Assets
32,620 GBP2025-05-31
32,620 GBP2024-05-31
Fixed Assets - Investments
498,970 GBP2025-05-31
498,970 GBP2024-05-31
Debtors
10,000 GBP2025-05-31
Cash at bank and in hand
14,039 GBP2025-05-31
51,271 GBP2024-05-31
Current Assets
24,039 GBP2025-05-31
51,271 GBP2024-05-31
Net Current Assets/Liabilities
-343,183 GBP2025-05-31
-335,950 GBP2024-05-31
Total Assets Less Current Liabilities
188,407 GBP2025-05-31
195,640 GBP2024-05-31
Net Assets/Liabilities
188,407 GBP2025-05-31
195,640 GBP2024-05-31
Equity
Called up share capital
300 GBP2025-05-31
300 GBP2024-05-31
Revaluation reserve
127,604 GBP2025-05-31
127,604 GBP2024-05-31
Retained earnings (accumulated losses)
60,503 GBP2025-05-31
67,736 GBP2024-05-31
Equity
188,407 GBP2025-05-31
195,640 GBP2024-05-31
Intangible Assets - Gross Cost
Other
32,620 GBP2025-05-31
32,620 GBP2024-05-31
Intangible Assets - Gross Cost
32,620 GBP2025-05-31
32,620 GBP2024-05-31
Intangible Assets
Other
32,620 GBP2025-05-31
32,620 GBP2024-05-31
Debtors
Amounts falling due within one year
10,000 GBP2025-05-31
Accrued Liabilities
Amounts falling due within one year
480 GBP2025-05-31
839 GBP2024-05-31
Corporation Tax Payable
Amounts falling due within one year
9,265 GBP2025-05-31
9,265 GBP2024-05-31
Average Number of Employees
12024-06-01 ~ 2025-05-31
12023-06-01 ~ 2024-05-31

  • KADEN BIOTECH LIMITED
    Info
    Registered number 12598519
    23 Leinster Terrace, London W2 3ET
    PRIVATE LIMITED COMPANY incorporated on 2020-05-12 (6 years). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-05-11
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.